- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/115 - Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith
Patent holdings for IPC class C12N 15/115
Total number of patents in this class: 2779
10-year publication summary
169
|
198
|
238
|
254
|
286
|
310
|
291
|
354
|
260
|
60
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Immatics Biotechnologies GmbH | 1144 |
361 |
SomaLogic Operating Co., Inc. | 230 |
48 |
NEC Solution Innovators, Ltd. | 596 |
47 |
The Regents of the University of California | 18943 |
38 |
City of Hope | 943 |
34 |
President and Fellows of Harvard College | 5792 |
32 |
CARIS Science, Inc. | 65 |
30 |
Ribomic Inc. | 40 |
27 |
Duke University | 2872 |
25 |
University of Cincinnati | 797 |
25 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
23 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
22 |
The Procter & Gamble Company | 22178 |
20 |
The University of Tokyo | 3903 |
20 |
Base pair Biotechnologies, Inc. | 25 |
19 |
Meiragtx UK II Limited | 57 |
18 |
Massachusetts Institute of Technology | 9795 |
17 |
University of Florida Research Foundation, Inc. | 3883 |
17 |
Rheinische Friedrich-Wilhelms-Universität Bonn | 196 |
17 |
Apterna Limited | 23 |
15 |
Other owners | 1924 |